Cano Health, Inc.
CANO · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $1 | $4 | $2 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $0 | $0 |
| Enterprise Value | $2 | $5 | $3 | $1 |
| Revenue | $3 | $2 | $1 | $0 |
| % Growth | 70.2% | 93.5% | 130.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 15.4% | 12.4% | 19.9% | 21.2% |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -7.2% | -3% | -2.2% | 4.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -15.6% | -7.3% | -8.5% | -8.2% |
| EPS Diluted | -87.6 | -24.54 | -42.75 | -17.86 |
| % Growth | -257% | 42.6% | -139.4% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |